NASDAQ · CJMB

Callan JMB Inc.

Closing price · Nov 13, 2026 $0.4084
Last insider buy price $1.75 Paid by Chief Medical Officer, 10% owner David Croyle on Mar 20, 2026 (Form 4). Not today's price.

Latest quarter · ended Jun 30, 2026

Sales slipped and cash got weaker

descriptionFiled Aug 14, 2026
Revenue growthShrinking
−17.4%
Quarter ended Mar 31, 2025: −19.1% sales vs. a year beforeQuarter ended Jun 30, 2025: −16.1% sales vs. a year beforeQuarter ended Sep 30, 2025: +0.8% sales vs. a year beforeQuarter ended Dec 31, 2025: −14.1% sales vs. a year beforeQuarter ended Mar 31, 2026: −23.7% sales vs. a year beforeQuarter ended Jun 30, 2026: −17.4% sales vs. a year before
Mar '25Jun '26
$1.38M vs. $1.67M a year ago
Gross marginBetter
55.1%
Quarter ended Sep 30, 2024: 32.4% gross marginQuarter ended Dec 31, 2024: 31.0% gross marginQuarter ended Mar 31, 2025: 42.5% gross marginQuarter ended Jun 30, 2025: 38.6% gross marginQuarter ended Sep 30, 2025: 34.1% gross marginQuarter ended Dec 31, 2025: 30.5% gross marginQuarter ended Mar 31, 2026: 38.6% gross marginQuarter ended Jun 30, 2026: 55.1% gross margin
Sep '24Jun '26
vs. 38.6% a year ago
Cash from operationsBetter
−$396K
Quarter ended Sep 30, 2024: $988K cash from operationsQuarter ended Dec 31, 2024: −$723K cash from operationsQuarter ended Mar 31, 2025: −$1.56M cash from operationsQuarter ended Jun 30, 2025: −$563K cash from operationsQuarter ended Sep 30, 2025: −$1.76M cash from operationsQuarter ended Dec 31, 2025: −$659K cash from operationsQuarter ended Mar 31, 2026: −$1.68M cash from operationsQuarter ended Jun 30, 2026: −$396K cash from operations
Sep '24Jun '26
vs. −$563K a year ago
Share countDiluting
+28.4%
Quarter ended Sep 30, 2024: 4.44M sharesQuarter ended Dec 31, 2024: 4.44M sharesQuarter ended Mar 31, 2025: 4.44M sharesQuarter ended Jun 30, 2025: 4.48M sharesQuarter ended Sep 30, 2025: 4.62M sharesQuarter ended Dec 31, 2025: 5.63M sharesQuarter ended Mar 31, 2026: 5.65M sharesQuarter ended Jun 30, 2026: 5.75M shares
Sep '24Jun '26
5.75M shares vs. 4.48M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −50
  • account_balance
    0 funds bought, 1 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

15 funds report owning CJMB, up from 12

Holdings as of Jun 30, 2026
New6
Added1
Held3
Trimmed5
Sold out3

Last quarter

Who bought and who sold

Apr–Jun 2026
Qsemble Capital Management, LP
−68%

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOpen-market buy · Dec 8 · $1.4KOpen-market buy · Dec 9 · $930Open-market buy · Dec 10 · $22.6KOpen-market buy · Dec 11 · $51KOpen-market buy · Dec 12 · $8.62KOpen-market buy · Dec 15 · $18.4KOpen-market buy · Dec 16 · $8.65KOpen-market buy · Dec 30 · $10KOpen-market buy · Mar 6 · $26.1KOpen-market buy · Mar 20 · $17.8K
CEOCFOOther officersDirectorsDecFebAprJunAugOctOpen-market buy · Dec 8 · $1.4KOpen-market buy · Dec 9 · $930Open-market buy · Dec 10 · $22.6KOpen-market buy · Dec 11 · $51KOpen-market buy · Dec 12 · $8.62KOpen-market buy · Dec 15 · $18.4KOpen-market buy · Dec 16 · $8.65KOpen-market buy · Dec 30 · $10KOpen-market buy · Mar 6 · $26.1KOpen-market buy · Mar 20 · $17.8K

Last 12 months. No real trades in the last 6.

Showing 10 real trades. Bigger dot means a bigger trade.

Real trades, newest first

Mar 20 David Croyle Chief Medical Officer, 10% owner Open-market buy $17.8K 10,195 sh at $1.75
Mar 6 David Croyle Chief Medical Officer, 10% owner Open-market buy $26.1K 14,805 sh at $1.76
Dec 30 Gerald Dial Director Open-market buy $7.6K 10,000 sh at $0.76
Dec 30 Gerald Dial Director Open-market buy $2.41K 2,000 sh at $1.20
Dec 16 Wayne Williams CEO, Chairman and President, Director, 10% owner Open-market buy $8.65K 5,000 sh at $1.73
Dec 15 Wayne Williams CEO, Chairman and President, Director, 10% owner Open-market buy $18.4K 10,810 sh at $1.70
Dec 12 Wayne Williams CEO, Chairman and President, Director, 10% owner Open-market buy $8.62K 4,926 sh at $1.75
Dec 11 Wayne Williams CEO, Chairman and President, Director, 10% owner Open-market buy $51K 30,918 sh at $1.65
Dec 10 Wayne Williams CEO, Chairman and President, Director, 10% owner Open-market buy $22.6K 13,689 sh at $1.65
Dec 9 Liberty Duke Director Open-market buy $930 612 sh at $1.52
Show 1 older real trade
Dec 8 Liberty Duke Director Open-market buy $1.4K 900 sh at $1.56

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in CJMB

As of Jun 30, 2026
FundOwnsValueChange
Qsemble Capital Management, LP<0.1%$378K−68%
Creative Planning4.4%$206KSame
Bard Associates Inc4.0%$184K−7%
Citadel Advisors LLC0.6%$25.8KNew
Axxcess Wealth Management, LLC0.4%$20.1KNew

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast